Form 8-K - Current report:
SEC Accession No. 0001564590-20-003267
Filing Date
2020-02-04
Accepted
2020-02-04 16:34:00
Documents
14
Period of Report
2020-02-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-8k_20200201.htm   iXBRL 8-K 58771
2 EX-3.1 nbix-ex31_19.htm EX-3.1 2415
3 EX-99.1 nbix-ex991_18.htm EX-99.1 642323
  Complete submission text file 0001564590-20-003267.txt   869449

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nbix-20200201.xsd EX-101.SCH 5976
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbix-20200201_lab.xml EX-101.LAB 19483
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbix-20200201_pre.xml EX-101.PRE 11633
7 EXTRACTED XBRL INSTANCE DOCUMENT nbix-8k_20200201_htm.xml XML 3547
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 20574255
SIC: 2836 Biological Products, (No Diagnostic Substances)